Secure Manufacturing Process IP via Provisional Patent & Exclusive Licenseback
- Organization
- CYTROGEN's focus on material composition patents rather than manufacturing scale-up methods
- Sector
- GMP contract manufacturers seeking exclusive partnerships with novel biomaterial technologies
- Location
- Location unspecified
Source Reference
Executive Context
NSF awarded $305K SBIR Phase I funding to CYTROGEN for Gelatrix, a light-curable bone adhesive, creating a research-funded entity with technical validation capital but zero commercial infrastructure, manufacturing partnerships, or market access pathways.
Catalyst / Timing
CYTROGEN's SBIR project focuses on material properties (light-curable, osteoinductive) but lacks protected manufacturing processes for GMP-scale production. Academic researchers typically patent compositions, not scalable manufacturing methods, creating an IP gap between lab synthesis and commercial production.
Projected Yield
5% royalty on projected $50-100M market → $2.5-5M annual royalty stream at scale
Structural Friction
• Vulnerability: CYTROGEN's SBIR project focuses on material properties (light-curable, osteoinductive) but lacks protected manufacturing processes for GMP-scale production. Academic researchers typically patent compositions, not scalable manufacturing methods, creating an IP gap between lab synthesis and commercial production. • Capital yield: 5% royalty on projected $50-100M market → $2.5-5M annual royalty stream at scale • Resource capture: Provisional patent portfolio on GMP manufacturing process • Sovereignty yield: Control over manufacturing partner selection for novel bone adhesive technology • Required vectors: Vector: Intellectual Property Law, Vector: Medical Device Manufacturing, Vector: Contract Negotiation & Deal Structuring
Required Capabilities
Vector: Intellectual Property Law
Primary executor: Phase 1: Manufacturing Method Gap Analysis: Hire contract patent searcher via Upwork to analyze all patents filed by Kha
Vector: Medical Device Manufacturing
Supporting vector for: Secure Manufacturing Process IP via Provisional Patent & Exclusive Licenseback
Vector: Contract Negotiation & Deal Structuring
Supporting vector for: Secure Manufacturing Process IP via Provisional Patent & Exclusive Licenseback
Execution Protocol
Execution Protocol Locked
A one-time payment of $1799 unlocks the exact wedge, required assets, and step-by-step execution parameters yours forever, no subscription.
This report is synthesized intelligence, not verified instruction. Always confirm against the primary source before acting. Review the full legal disclaimer before proceeding.